TriClip Japan Post-Approval Study
Recruiting
Observational Study
Tricuspid Regurgitation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Abbott Medical Devices · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Japanese population and to fulfill post-market requirements following commercial approval in Japan.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects are eligible to receive the TriClip System per the current approved indications for use (IFU)
* Subjects provide written informed consent prior to conducting any investigation-specific procedures not considered standard of care.
Exclusion Criteria:
* There are no ex…
Contacts